American Society of Hirudotherapy

Microvascular ear replantation: a multicenter study of 22 patients with complete ear amputation

Multicenter study published in Facial Plast Surg Aesthet Med (2021)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyClinical TrialsJiang Y et al. · Facial plastic surgery & aesthetic medicine, 2021

Abstract

Background: We aimed to report our experience in treating ear amputations with microvascular replantation, with the largest sample to date. Methods: Twenty-two patients with complete ear amputation underwent microvascular ear replantation at three medical centers between May 2003 and May 2020. Arterial anastomoses, venous anastomoses, or vein graft were performed depending on different situations. Re-exploration was performed in four patients due to venous congestion (n = 3) or arterial compromise (n = 1). Results: Eleven patients had vascular complications (venous congestion: 10, arterial compromise: 1) and four of them required re-exploration. Three ears were completely salvaged (75%) and one case failed. Eighteen (81.8%) replanted ears survived completely, with 15 repaired ears demonstrating a good contour and 3 ears showing atrophy. Three replanted ears sustained partial loss, and one sustained total loss. Three extraordinary cases with the longest ischemic time, smallest tissue size, and youngest age reported thus far all survived and had cosmetically satisfactory appearances. Statistical analysis indicated no significant correlation between replanted ear survival and potentially influential factors, including ischemic time, number of arterial and venous anastomoses, presence of vein graft, and re-exploration. Conclusions: Microvascular replantation for ear amputations achieved excellent results. It may be considered the primary choice for surgeons with microsurgical skill.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov't
Indexed MeSH termsHumansReplantationMaleFemaleAdultAmputation, TraumaticMiddle AgedAdolescentMicrosurgeryEar, ExternalYoung AdultChild

Summary

Largest-to-date series of 22 microvascular ear replantations across 3 centers. 81.8% complete survival; 11/22 had vascular complications including 10 venous congestion cases.

Why This Matters for Hirudotherapy

This multicenter study reports outcomes of microvascular ear replantation in 22 patients with complete ear amputation, achieving an 81.8% complete survival rate. Venous congestion was the most common vascular complication (10 of 22 patients). The study makes no mention of leech therapy or hirudotherapy. While ear replantation complicated by venous congestion is a clinical scenario where medicinal leeches are sometimes employed adjunctively, this study does not describe any leech-related intervention. Relevance to ASH's domain is indirect, limited to the surgical context where venous congestion management challenges arise. The focus is on surgical technique and outcomes rather than adjunctive congestion therapies.

Citation

Microvascular ear replantation: a multicenter study of 22 patients with complete ear amputation.

Jiang Y et al. · Facial plastic surgery & aesthetic medicine, 2021

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.